Home › Trial NCT00780143
Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
- Trial IDNCT00780143
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorPharmaMar
- Enrollment3
- Start date2007-11
- ConditionsRelapsed/Refractory Leukemia
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.